Rajiv Agarwal, MD, BS, a renowned nephrology expert, discusses the importance of early detection and treatment of chronic kidney disease (CKD), particularly in patients with type 2 diabetes. He highlights the lack of awareness and insufficient screening for CKD as major issues. He emphasized the need for annual screening for CKD in diabetic patients, which should include measuring creatinine for estimated GFR and albuminuria through a urine test. Dr Agarwal also discussed the evolution of CKD treatment guidelines, mentioning the advent of SGLT-2 inhibitors and non-steroidal MRA. He stressed the importance of communicating the benefits of these new therapies to patients to encourage their adoption. He concluded by reiterating the need for albuminuria screening and the use of various treatments, including ACEs and ARBs, SGLT-2 inhibitors, finerenone, and GLP-1 RAs.